Catalyst Pharmaceuticals, Inc. Ratios

1Y3Y5Y7Y10YAll
Download Data
Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 85.57%85.69%84.46%83.94%86.95%86.00%
EBT Margin -819.36%-6,800.70%32.66%35.18%37.40%48.89%23.73%43.98%
EBIT Margin -823.01%-7,059.03%31.11%34.69%37.20%47.54%21.80%39.68%
EBITDA Margin -823.01%-6,804.75%31.19%62.99%27.91%38.87%17.93%33.34%
Operating Margin -823.01%-7,059.03%31.11%34.69%37.20%47.54%21.80%39.68%
Net Margin -819.36%-6,800.70%31.16%62.97%28.03%38.79%14.95%33.23%
FCF Margin -769.04%-5,247.91%33.81%37.81%42.14%54.16%36.00%48.65%
Efficiency
Inventory Average 1.01M3.30M6.26M7.34M11.22M17.59M
Assets Average 21.08M34.64M52.00M50.90M63.55M72.92M86.41M152.37M215.07M306.71M422.87M660.76M
Equity Average 18.01M28.32M45.36M47.39M60.14M65.87M69.21M128.61M188.21M253.63M344.15M557.76M
Invested Capital 5.52M14.62M21.39M35.24M55.48M39.31M80.96M50.78M87.63M169.60M206.83M300.42M387.88M727.63M
Asset Utilization Ratio 0.011.180.780.650.700.940.74
Leverage & Solvency
Equity Ratio 0.950.870.840.800.920.940.950.840.780.880.870.800.830.85
Valuation
Enterprise Value 11.36M18.78M31.86M6.20M102.13M169.72M148.24M46.61M249.26M262.96M291.91M205.91M506.84M1,216.69M1,578.45M1,971.68M
Market Capitalization 11.36M24.25M31.86M15.12M121.83M205.28M202.92M87.01M333.27M316.44M386.43M346.19M698.11M1,515.08M1,716.09M2,489.24M
Return Ratios
Return on Sales -8.19%-68.01%0.31%0.63%0.28%0.39%0.15%0.33%
Return on Capital Employed -0.54%-0.51%-0.42%-0.40%-0.32%-0.56%0.51%0.32%0.28%0.41%0.25%0.36%
Return on Invested Capital 0.44%0.21%0.32%0.16%0.26%
Return on Assets -0.58%-0.45%-0.39%-0.36%-0.29%-0.47%0.37%0.49%0.18%0.27%0.14%0.25%
Return on Equity -0.68%-0.55%-0.45%-0.38%-0.31%-0.52%0.46%0.58%0.21%0.33%0.17%0.29%